185 related articles for article (PubMed ID: 36681936)
1. Genetic control of RNA editing in neurodegenerative disease.
Wu S; Xue Q; Yang M; Wang Y; Kim P; Zhou X; Huang L
Brief Bioinform; 2023 Mar; 24(2):. PubMed ID: 36681936
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation and microRNA targeting of A-to-I RNA editing fine tune human tissue transcriptomes.
Park E; Jiang Y; Hao L; Hui J; Xing Y
Genome Biol; 2021 Mar; 22(1):77. PubMed ID: 33685485
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract][Full Text] [Related]
4. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
[TBL] [Abstract][Full Text] [Related]
5. Transcriptomic analysis reveals associations of blood-based A-to-I editing with Parkinson's disease.
Li W; Wu H; Li J; Wang Z; Cai M; Liu X; Liu G
J Neurol; 2024 Feb; 271(2):976-985. PubMed ID: 37902879
[TBL] [Abstract][Full Text] [Related]
6. The Potential Regulation of A-to-I RNA Editing on Genes in Parkinson's Disease.
Wu S; Xue Q; Qin X; Wu X; Kim P; Chyr J; Zhou X; Huang L
Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107677
[TBL] [Abstract][Full Text] [Related]
7. Genetic Determinants of RNA Editing Levels of ADAR Targets in Drosophila melanogaster.
Kurmangaliyev YZ; Ali S; Nuzhdin SV
G3 (Bethesda); 2015 Dec; 6(2):391-6. PubMed ID: 26656153
[TBL] [Abstract][Full Text] [Related]
8. Genomic, transcriptomic and RNA editing analysis of human MM1 and VV2 sporadic Creutzfeldt-Jakob disease.
Tarozzi M; Baiardi S; Sala C; Bartoletti-Stella A; Parchi P; Capellari S; Castellani G
Acta Neuropathol Commun; 2022 Dec; 10(1):181. PubMed ID: 36517866
[TBL] [Abstract][Full Text] [Related]
9. GPEdit: the genetic and pharmacogenomic landscape of A-to-I RNA editing in cancers.
Ruan H; Li Q; Liu Y; Liu Y; Lussier C; Diao L; Han L
Nucleic Acids Res; 2022 Jan; 50(D1):D1231-D1237. PubMed ID: 34534336
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome-wide modulation of splicing by the exon junction complex.
Wang Z; Murigneux V; Le Hir H
Genome Biol; 2014; 15(12):551. PubMed ID: 25476502
[TBL] [Abstract][Full Text] [Related]
11. Incorporating alternative splicing and mRNA editing into the genetic analysis of complex traits.
Hassan MA; Saeij JP
Bioessays; 2014 Nov; 36(11):1032-40. PubMed ID: 25171292
[TBL] [Abstract][Full Text] [Related]
12. A Systematic Review of Common and Brain-Disease-Specific RNA Editing Alterations Providing Novel Insights into Neurological and Neurodegenerative Disease Manifestations.
Karagianni K; Pettas S; Christoforidou G; Kanata E; Bekas N; Xanthopoulos K; Dafou D; Sklaviadis T
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327657
[TBL] [Abstract][Full Text] [Related]
13. The landscape of the A-to-I RNA editome from 462 human genomes.
Ouyang Z; Ren C; Liu F; An G; Bo X; Shu W
Sci Rep; 2018 Aug; 8(1):12069. PubMed ID: 30104667
[TBL] [Abstract][Full Text] [Related]
14. EIF4A3: a gatekeeper of autophagy.
Sakellariou D; Frankel LB
Autophagy; 2021 Dec; 17(12):4504-4505. PubMed ID: 34643458
[TBL] [Abstract][Full Text] [Related]
15. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
[TBL] [Abstract][Full Text] [Related]
16. Hsa_circ_0030042 regulates abnormal autophagy and protects atherosclerotic plaque stability by targeting eIF4A3.
Yu F; Zhang Y; Wang Z; Gong W; Zhang C
Theranostics; 2021; 11(11):5404-5417. PubMed ID: 33859754
[No Abstract] [Full Text] [Related]
17. Contribution of copy number variants involving nonsense-mediated mRNA decay pathway genes to neuro-developmental disorders.
Nguyen LS; Kim HG; Rosenfeld JA; Shen Y; Gusella JF; Lacassie Y; Layman LC; Shaffer LG; Gécz J
Hum Mol Genet; 2013 May; 22(9):1816-25. PubMed ID: 23376982
[TBL] [Abstract][Full Text] [Related]
18. DHX9 suppresses RNA processing defects originating from the Alu invasion of the human genome.
Aktaş T; Avşar Ilık İ; Maticzka D; Bhardwaj V; Pessoa Rodrigues C; Mittler G; Manke T; Backofen R; Akhtar A
Nature; 2017 Apr; 544(7648):115-119. PubMed ID: 28355180
[TBL] [Abstract][Full Text] [Related]
19. Atlas of RNA editing events affecting protein expression in aged and Alzheimer's disease human brain tissue.
Ma Y; Dammer EB; Felsky D; Duong DM; Klein HU; White CC; Zhou M; Logsdon BA; McCabe C; Xu J; Wang M; Wingo TS; Lah JJ; Zhang B; Schneider J; Allen M; Wang X; Ertekin-Taner N; Seyfried NT; Levey AI; Bennett DA; De Jager PL
Nat Commun; 2021 Dec; 12(1):7035. PubMed ID: 34857756
[TBL] [Abstract][Full Text] [Related]
20. Sanguinarine inhibits epithelial ovarian cancer development via regulating long non-coding RNA CASC2-EIF4A3 axis and/or inhibiting NF-κB signaling or PI3K/AKT/mTOR pathway.
Zhang S; Leng T; Zhang Q; Zhao Q; Nie X; Yang L
Biomed Pharmacother; 2018 Jun; 102():302-308. PubMed ID: 29571014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
